(Q45035153)
Statements
Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy (English)
Sheena Premecz
Jordyn Lerner
Piotr Wtorek
Megan Dasilva
Devin Hasanally
Rakesh Chaudhary
Anita Sharma
James Thliveris
Amir Ravandi
16 November 2013